LCIG in treatment of non‐motor symptoms in advanced Parkinson’s disease: Review of literature

Volume: 10, Issue: 9
Published: Jul 16, 2020
Abstract
Background For managing nonmotor symptoms (NMS) in advanced Parkinson's disease (PD), levodopa–carbidopa intestinal gel (LCIG) infusion is of interest as it shows lesser plasma fluctuations of both drugs as compared to oral levodopa–carbidopa (LC). Objectives To highlight LCIG effect in NMS among advanced PD patients and appraise the currently available literature. Methods PubMed screening (till 2020) of 184 articles was done, of which 51 were...
Paper Details
Title
LCIG in treatment of non‐motor symptoms in advanced Parkinson’s disease: Review of literature
Published Date
Jul 16, 2020
Volume
10
Issue
9
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.